Financial Performance - The basic earnings per share for Q1 2025 is 0.0800 yuan, a decrease of 11.11% compared to Q1 2024, which was 0.0900 yuan [1] - The net profit for Q1 2025 is 0.17 billion yuan, down 10.53% from 0.19 billion yuan in Q1 2024 [1] - The operating revenue for Q1 2025 is 2.26 billion yuan, a decline of 3% from 2.33 billion yuan in Q1 2024 [1] - The return on equity for Q1 2025 is 3.06%, a decrease of 15% compared to 3.60% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 800.15 million shares, accounting for 13.69% of the circulating shares, with an increase of 110.22 million shares compared to the previous period [1] - Liu Wen holds 268.97 million shares, representing 4.60% of the total share capital, with no change [2] - Zhou Dian has newly entered the list with 178.57 million shares, accounting for 3.05% [2] - Zeng Zhiguang has reduced his holdings by 15.78 million shares, now holding 132.16 million shares, which is 2.26% [2] Dividend Policy - The company will not distribute dividends or transfer shares this time [3]

Financial Performance - In 2024, the company's operating revenue was CNY 906,395,950.71, a decrease of 6.77% compared to CNY 972,200,970.94 in 2023[24] - The gross profit margin improved to 16.56% in 2024, up from 14.19% in 2023[24] - The net profit attributable to shareholders increased by 5.65% to CNY 45,599,946.13 in 2024, compared to CNY 43,161,415.83 in 2023[24] - The company achieved a basic earnings per share of CNY 0.2220, reflecting a 3.16% increase from CNY 0.2152 in 2023[24] - Total assets increased to ¥688,295,117.90, representing a growth of 5.34% compared to the end of 2023[26] - Total liabilities rose to ¥136,917,317.59, marking a 7.02% increase from the end of 2023[26] - Operating cash flow increased by 28.19% to ¥71,874,267.99 from ¥56,067,144.52 in 2023[26] - The total profit for 2024 was 57.09 million yuan, reflecting a year-on-year increase of 5.72%[38] - The company reported a significant increase in asset impairment losses, which rose by 2,529.60% to 6,373,437.69, primarily due to increased inventory write-downs[54] Research and Development - The company was recognized as a high-tech enterprise in December 2024, affirming its commitment to R&D and innovation[7] - The company plans to continue enhancing its R&D capabilities to strengthen its core competitiveness in the market[7] - Research and development expenses for 2024 amounted to 16.74 million yuan, representing 1.85% of operating revenue[38] - The company maintains a strong focus on R&D, developing a wide range of egg products to meet evolving consumer demands[35] - The total number of patents owned by the company increased to 23 from 18 in the previous period, with the number of invention patents rising to 9 from 7[76] - The company has 27 R&D personnel, maintaining a ratio of 6.8% of total employees[75] - The company is currently developing new products, including high-toughness egg skins and enzyme extraction technologies, aimed at expanding market share and improving product structure[78][79] - The company has ongoing collaborations with universities for research on egg product preservation and nutritional supplementation[79][80] Market Strategy and Expansion - The company is actively expanding its sales channels, focusing on a diversified sales matrix across industrial, catering, e-commerce, and retail sectors[39] - The company plans to enhance its core competitiveness through continuous technological innovation and product upgrades[38] - The company is focused on enhancing its value chain competitiveness through a three-dimensional strategy of geographic layout, industrial upgrading, and ecological collaboration[90] - The company plans to expand its market share by implementing a strategy of "core market cultivation + emerging market penetration" to establish a deep coverage network[90] - The company aims to upgrade traditional egg product processing technology to improve production efficiency and product quality, while also expanding into high-value sectors such as prepared dishes and health products[90] - The company emphasizes the importance of brand building and quality competition in response to increasing consumer demands for egg quality, safety, and freshness[89] - The company is focusing on two emerging areas: customized healthy dining solutions for light meal chains and nutritious egg products for the elderly, tapping into new consumer scenarios[92] Corporate Governance and Management - The company has established a new public opinion management system to enhance its governance structure[152] - The company has implemented a comprehensive labor contract system and provided social insurance for all employees, including pension and medical insurance[143] - The company has established a clear investor relations management system to enhance communication and transparency with investors[162] - The company has maintained independence in operations, finance, and personnel, ensuring no conflicts of interest with controlling shareholders[169][170][171] - The company has implemented various communication methods with investors, including a hotline and email, to enhance interaction and transparency[177] - The company has established a complete internal control system, ensuring compliance and asset security, with no significant internal control deficiencies reported during the period[173] - The company has a dedicated board secretary responsible for investor relations, ensuring effective communication with stakeholders[162] Shareholder Information - The largest shareholder, CHINA EGG PRODUCTS ApS, holds 135,188,506 shares, representing 65.80% of total shares[115] - The company has a clear and transparent cash dividend policy, ensuring the protection of minority shareholders' rights[128] - The total remuneration for the board of directors, supervisors, and senior management for the year 2024 is 13.7028 million yuan[141] - The total number of ordinary shares is 205,445,536, with no changes during the period[113] - The company has not reported any pledges or judicial freezes on shares held by major shareholders[118] - The company has not undergone any changes in its controlling shareholder or actual controller during the reporting period[119] Financial Management - The company has implemented a credit loss model for accounts receivable, ensuring the accuracy of bad debt provisions based on aging and expected credit loss parameters[83] - The company has established a comprehensive internal control system to mitigate risks associated with its actual controller's influence and potential product quality issues[95] - The company has not identified any major deficiencies in its accounting, financial management, or risk control systems during the reporting period[151] - The audit opinion for the financial statements was unqualified, indicating no significant issues were found[179] - The financial statements were prepared in accordance with accounting standards, fairly reflecting the company's financial position as of December 31, 2024[180] Social Responsibility - The company actively participates in social responsibility initiatives, including supporting the first egg product technology museum in Shanghai, which aims to educate consumers about egg production and nutritional value[86]

Financial Data and Indicators - The basic earnings per share for 2024 is 0.2220 yuan, an increase of 3.16% compared to 0.2152 yuan in 2023 [1] - The net asset per share for 2024 is 2.68 yuan, reflecting a 4.69% increase from 2.56 yuan in 2023 [1] - The undistributed profits per share increased by 13.25% to 0.94 yuan in 2024 from 0.83 yuan in 2023 [1] - The operating revenue for 2024 is 9.06 billion yuan, a decrease of 6.79% from 9.72 billion yuan in 2023 [1] - The net profit for 2024 is 0.46 billion yuan, which is a 6.98% increase from 0.43 billion yuan in 2023 [1] - The return on equity for 2024 is 8.50%, slightly down by 0.58% from 8.55% in 2023 [1] Shareholder Information - The top ten unrestricted shareholders hold a total of 689.93 million shares, accounting for 11.96% of the circulating shares, with an increase of 139.62 million shares compared to the previous period [1] - New significant shareholders include Liu Wen with 268.97 million shares (4.66%), Zeng Zhiguang with 147.94 million shares (2.56%), and Zeng Yingshen with 78.64 million shares (1.36%) [2] - Several shareholders have exited the top ten list, including Zeng Xingsheng with 109.13 million shares (2.01%) and Kaiyuan Securities with 101.49 million shares (1.87%) [2]

苏州欧福蛋业股份有限公司 控 股 股 东 及 其 他 关 联 方 资 金 占 用 情 况 的 专项说明 天职业字[2025]21122 号 目 录 -1 控股股东及其他关联方资金占用情况的专项说明 --- -2 2024年度非经营性资金占用及其他关联资金往来情况汇总表 ------- 地可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ace.nef.gov.cn）"进行了 "我可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ace.nef.gov.cn）"进行了 控股股东及其他关联方资金占用情况的专项说明 天职业字[2025]21122 号 苏州欧福蛋业股份有限公司董事会: 我们审计了苏州欧福蛋业股份有限公司(以下简称"欧福蛋业")财务报表,包括2024 年12月31日的合并及母公司资产负债表、2024年度的合并及母公司利润表、合并及母公司现 金流量表、合并及母公司股东权益变动表以及财务报表附注,并于2025年4月25日签署了标 准无保留意见的审计报告。 中国注册会计师: 中国注册会计师: 根据中国证监会、公安部、国资委、中国银保监会《上市公司监管指引第8号 -- ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2025-023 苏州欧福蛋业股份有限公司董事、监事换届公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律 责任。 一、换届基本情况 （一）董事换届的基本情况 根据《公司法》及公司章程的有关规定，公司第三届董事会第二十三次会议于 2025 年 4 月 25 日审议并通过： 提名 Henrik Pedersen 先生为公司董事，任职期限三年，本次换届尚需提交股东大会 审议，自 2024 年年度股东大会决议通过之日起生效。上述提名人员持有公司股份 0 股， 占公司股本的 0%，不是失信联合惩戒对象。 提名 Thor Stadil 先生为公司董事，任职期限三年，本次换届尚需提交股东大会审 议，自 2024 年年度股东大会决议通过之日起生效。上述提名人员持有公司股份 0 股， 占公司股本的 0%，不是失信联合惩戒对象。 提名 Ronald Bouwens 先生为公司董事，任职期限三年，本次换届尚需提交股东大 会审议，自 2024 年年度股东大会决议通过之日起生效。 ...

一、募集资金基本情况 （一）募集资金到位情况 2022 年 12 月 14 日，中国证券监督管理委员会出具《关于同意苏州欧福蛋业股份有限公 司向不特定合格投资者公开发行股票注册的批复》（证监发行字[2022]3128 号），同意公司向 不特定合格投资者公开发行股票的注册申请。公司本次发行股数为 5,175.00 万股（超额配售 选择权行使后），募集资金合计为人民币 129,375,000.00 元，扣除发行费用后的募集资金净额 为 112,822,477.86 元。募集资金到账时间为 2023 年 1 月 10 日和 2023 年 2 月 17 日（行使超额 配售选择权的募集资金），募集资金到位情况已经天职国际会计师事务所（特殊普通合伙）审 验，并出具了天职业字[2023]1228 号及天职业字[2023]6333 号验资报告。 （二）募集资金专户存储情况 截至 2024 年 12 月 31 日，公司募集资金专户存放情况如下： 申万宏源证券承销保荐有限责任公司 关于苏州欧福蛋业股份有限公司 2024 年度募集资金存放与使用情况的专项报告 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"或"保荐机 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2025-012 2024 年度独立董事年度述职报告（吴英华） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 2024 年度，本人吴英华作为苏州欧福蛋业股份有限公司（以下简称"公司"） 的独立董事，在任职期间严格按照《公司法》《证券法》《北京证券交易所股票上 市规则（试行）》《北京证券交易所上市公司持续监管指引第 1 号——独立董事》 等法律法规、规范性文件及《公司章程》《独立董事工作制度》等相关规定，勤 勉尽责，积极出席各项会议，认真审议各项提案并提出建议，始终维护全体股东 尤其是中小股东的利益，切实履行了独立董事的责任与义务。现就 2024 年度履 职情况汇报如下： 一、独立董事基本情况及独立性情况 吴英华，女，1970 年出生，中国国籍，无境外永久居留权，本科学历。1993 年 7 月至今 1999 年 12 月，就职于江苏吴江会计师事务所，任业务一部审计； 2000 年 1 月至今，就职于吴江华正会计师事务所有限公司，历任部门经理、公 司董 ...

天职业字[2025]21121 号 " 报告编码:泉 募集资金年度存放与使用情况鉴证报告 苏 州 欧 福 蛋 业 股 份 有 限 公 司 募 集 资 金 年 度 存 放 与 使 用 情 况 鉴 证 报 告 天 职 业 字 [2025]21121 号 目 求 募集资金年度存放与使用情况鉴证报告- l 关于募集资金年度存放与使用情况的专项报告— -3 苏州欧福蛋业股份有限公司全体股东: 我们审核了后附的苏州欧福蛋业股份有限公司(以下简称"贵公司")《苏州欧福蛋业股份 有限公司董事会关于募集资金年度存放与使用情况的专项报告》。 一、管理层的责任 贵公司管理层的责任是按照中国证监会《上市公司监管指引第2号 -- 上市公司募集资金 管理和使用的监管要求》、北京证券交易所颁布的《北京证券交易所股票上市规则(试行)》等 相关规定编制《苏州欧福蛋业股份有限公司董事会关于募集资金年度存放与使用情况的专项报 告》,并保证其内容的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责任是按照《中国注册会计师其他鉴证业务准则第 3101 号 -- 历史财务信息审计 或审阅以外的鉴证业务》的规定执行鉴 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2025-026 苏州欧福蛋业股份有限公司 独立董事候选人声明与承诺（杨严俊） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 本人杨严俊，已充分了解并同意由提名人董事会提名为苏州欧福蛋业股份有 限公司第四届董事会独立董事候选人。本人公开声明，本人具备独立董事任职资 格，保证不存在任何影响本人担任苏州欧福蛋业股份有限公司独立董事独立性的 关系，具体声明并承诺如下： 一、本人已同时符合以下条件： （一）具备上市公司运作的基本知识，熟悉相关法律法规、部门规章、规范 性文件及北交所业务规则； （二）具有五年以上履行独立董事职责所必需的法律、会计或者经济等工作 经验； （三）具有良好的个人品德，不存在重大失信等不良记录； （四）北交所规定的其他条件。 二、本人任职资格符合下列法律法规、部门规章、规范性文件及北交所业务 规则的要求： （一）《公司法》关于董事任职资格的规定； （二）《中华人民共和国公务员法》的相关规定； （三）中国证监会《上市公司独立董事管理办 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2025-018 苏州欧福蛋业股份有限公司 董事会关于独立董事独立性情况的专项意见 （三）独立董事及其配偶、父母、子女不是直接或间接持有公司已发行股份 百分之五以上的股东，未在公司前五名股东任职； （四）独立董事及其配偶、父母、子女未在公司控股股东、实际控制人的附 属企业任职； （五）独立董事不是公司及公司控股股东、实际控制人或者其各自的附属企 业有重大业务往来的人员，未在有重大业务往来的单位及其控股股东、实际控制 人任职； （六）独立董事不是为公司及公司控股股东、实际控制人或者其各自附属企 业提供财务、法律、咨询、保荐等服务的人员，包括但不限于提供服务的中介机 构的项目组全体人员、各级复核人员、在报告上签字的人员、合伙人、董事、高 级管理人员及主要负责人； （七）独立董事最近十二个月内未曾经具有第一项至第六项所列举情形； （八）独立董事不是法律、行政法规、中国证监会规定、证券交易所业务规 则和公司章程规定的不具备独立性的其他人员。 综上，董事会认为公司在任独立董事具备任职条件，不存在影响其独立性的 情形。 苏州欧福蛋业股份有限公司 本公司及董事会全体成员 ...